LIN: FY25 Deep Dive
FY25 revenue $34.0B (+3%) — adjusted operating margin held 29.8% (vs 29.5% FY24). Sale-of-gas project backlog $7.3B end-FY25. Capital return $7.4B = 145% of FCF on Linde's signature lever-and-buyback model. Five covered actions Feb-April were all maintains — every PT raised, JPM upgraded back to OW.
Key Takeaways
Linde plc closed fiscal 2025 (calendar year ended December 31, 2025) at $34.0 billion of total revenue, up 3% reported YoY — a typical Linde print where pricing + fixed-fee on-site contracts compounded against modestly soft volumes in cyclical end markets (chemicals, manufacturing). The structural feature is that adjusted operating margin held 29.8% (vs 29.5% FY24, 29.0% FY23 implied) — a continued multi-decade compounding upward trend that is the single cleanest "best-in-class operator" signal in the industrials sector. Reported operating income was $8.92 billion (26.3% reported margin); adjusted operating income $10.14 billion (29.8% adjusted). Net income reached $6.90 billion ($14.61 GAAP EPS); adjusted net income $7.77 billion ($16.46 adjusted EPS, +6%). Operating cash flow stepped up $0.93B to $10.35 billion (+10%); capex $5.26 billion (+17%, reflecting backlog conversion); free cash flow $5.09 billion. Capital return reached $7.39 billion ($4.58B buybacks + $2.81B dividends — DPS raised 8% to $6.00, the 31st consecutive year of dividend increase). The sale-of-gas project backlog was $7.3 billion at year-end, the forward-revenue visibility lever for FY26-FY28. Sell-side coverage in the Feb-April 2026 window: 8 covered actions, all maintain or upgrade, zero PT cuts. JPMorgan downgraded to Neutral on Feb 6 then upgraded back to Overweight on March 13 with a $70 PT raise to $525. Consensus PT $562.20, range $525-$580.
Main business structure
Linde reports four geographic operating segments plus an "Other" basket:
| Segment | FY25 ($M) | % of Total | YoY |
|---|---|---|---|
| Americas | 15,208 | 44.7% | +5% |
| EMEA | 8,549 | 25.2% | +2% |
| APAC | 6,661 | 19.6% | flat |
| Engineering | 2,250 | 6.6% | -3% |
| Other | 1,318 | 3.9% | +5% |
| Total | 33,986 | 100% | +3% |
Revenue by distribution method (FY25):
| Method | $M | % of Total |
|---|---|---|
| Packaged Gas | 11,853 | 35% |
| Merchant | 10,159 | 30% |
| On-Site | 8,083 | 24% |
| Other (incl Engineering) | 3,891 | 11% |
Americas (~45% of revenue) is the largest geographic segment. The +5% growth in FY25 reflects pricing-led growth on a stable installed base, plus continued large-project wins for hydrogen / blue-ammonia plants in the US Gulf Coast (Linde Clean Energy strategy). Margins typically run 28-30% in Americas — at the high end of the company average.
EMEA (~25%) grew +2% with mixed underlying dynamics: Western European industrial weakness (chemicals + manufacturing soft) offset by pricing and Eastern Europe / MENA project ramp.
APAC (~20%) was flat in FY25 — the softest geographic segment. China industrial gas demand has been mixed (steel + chemicals weak; semiconductor + electronics demand holding). Australia / Korea / Japan stable.
Engineering (~7%) is the project engineering / EPC business — building large air separation units, hydrogen plants, and gas processing equipment for third-party customers (and Linde itself). The -3% in FY25 reflects project lumpiness in the EPC business.
Distribution model. Linde generates revenue through three distinct models: on-site (pipeline / on-site plant supply, typically with 15-20-year take-or-pay contracts to industrial customers), merchant (bulk liquid delivery to mid-size customers), and packaged gas (cylinder gas to small/medium customers). The on-site book provides multi-decade revenue visibility — these contracts compound and the asset depreciates against fixed pricing escalators.
Project backlog. The sale-of-gas backlog of large projects under construction was $7.3 billion at end-FY25 — capital cost of large plants currently under construction. This converts to revenue over the FY26-FY28 horizon as plants reach commissioning.
Customer concentration. Industrial gas customers are highly diversified across chemicals, refining, steel, glass, electronics, healthcare, food & beverage. No single customer above 10% disclosure.
Scale anchors. ~66,000 employees globally. Operations in 80+ countries. The largest industrial gas company in the world (#1 globally by revenue).
Key core metrics (3-year trend)
1. Revenue and margin compounding
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Revenue ($B) | 32.85 | 33.01 | 33.99 |
| YoY | — | +0.5% | +3% |
| Reported OpMargin | 24.7% | 26.2% | 26.3% |
| Adjusted OpMargin | ~29.0% | 29.5% | 29.8% |
Adjusted operating margin has compounded 80bp over the last two reported years — the cleanest decade-long industrial-margin compounding profile in mega-cap industrials.
2. EPS (adjusted) compounding
| FY24 | FY25 | |
|---|---|---|
| Adjusted diluted EPS | ~$15.50 (implied) | $16.46 |
| YoY | — | +6% |
The +6% adjusted EPS growth is pricing + margin expansion + buyback share-count benefit — the "Linde recipe" that compounds in any volume environment.
3. Free cash flow and capex
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| OCF ($B) | 9.31 | 9.42 | 10.35 |
| Capex ($B) | 3.79 | 4.50 | 5.26 |
| FCF ($B) | 5.52 | 4.93 | 5.09 |
Capex stepped up to $5.26B in FY25 (+17% YoY) reflecting the backlog conversion phase — building out the $7.3B large-project pipeline. The capex step-up is a forward-revenue investment, not a margin headwind.
4. Capital return — the deleveraging-and-buyback model
| FY23 | FY24 | FY25 | |
|---|---|---|---|
| Buybacks ($B) | 3.96 | 4.45 | 4.58 |
| Dividends ($B) | 2.48 | 2.66 | 2.81 |
| DPS ($) | — | $5.56 | $6.00 |
| Total return ($B) | 6.44 | 7.11 | 7.39 |
| Capital return / FCF | 117% | 144% | 145% |
Linde returns ~145% of FCF to shareholders via debt-funded buybacks — the structural lever that compounds EPS faster than FCF. Dividend per share grew 8% to $6.00 (31st consecutive annual increase).
Market evaluation
Sell-side coverage (as of April 27, 2026). Coverage shown in the Feb-April 2026 actions: 5 actively-tracked Buy/Outperform names plus JPMorgan / Citi rotations. Consensus is uniformly Buy — 5/5 of tracked.
| Rating (covered universe) | Count |
|---|---|
| Buy / Outperform / Overweight | 5 |
| Hold | 0 |
| Sell | 0 |
Price targets. Consensus $562.20, range $525 (low: JPMorgan, OW post-upgrade) to $580 (high: Citi).
Recent analyst activity (February through April 2026). 8 covered actions in the window — including a notable JPMorgan rating flip:
- JPMorgan (Jeffrey Zekauskas): downgraded to Neutral at $455 on February 6 — the only rating downgrade in the period — then upgraded back to Overweight at $525 on March 13 (+$70 PT). The flip-then-flip-back is unusual but signals a thesis-validation reset around Q4 FY25 results.
- UBS (Joshua Spector): $500 → $550 (Feb 6) → $579 (April 9) — Buy maintained, cumulative +$79
- Citi (Patrick Cunningham): $540 → $545 (Feb 6) → $580 (April 13) — Buy maintained, +$40 cumulative, Street-high
- RBC Capital (Arun Viswanathan): $552 on April 24 — OP maintained
- All other actions were PT raises with rating maintains
The cleanest pattern is that every dollar-direction in the window was upward (no PT cuts) and the one downgrade (JPM) was reversed within 5 weeks — a striking signal of Street consensus durability.
Buy-side positioning. LIN is a core industrial holding — defensive growth, mid-single-digit revenue compound with margin expansion. Often paired with NEE (utilities) as a "compounder" basket. Short interest below 1.5% of float.
FY25 corporate structure: the compounder template stays intact
FY25 is another year of the Linde compounder template printing on schedule. Volume modest (+1% organic implied), pricing carrying mid-single-digit, adjusted operating margin +30bp to 29.8%, adjusted EPS +6% to $16.46, capital return $7.4B at 145% of FCF, project backlog stable at $7.3B for FY26-FY28 conversion. The structural read in the FY25 10-K is that the on-site contract economics keep compounding through any cycle: ~24% of revenue is on-site / fixed-fee with multi-decade contracts, and pricing escalators carry the mid-single-digit baseline. The two FY25 watch items: (1) the $5.26B capex step-up (+17% YoY) — backlog conversion is the right capital deployment, but it tightens FCF in the build-out years before plants commission; (2) the JPMorgan flip-then-upgrade pattern — Street briefly questioned whether margin had peaked in early February, then revalidated by mid-March. The Q1 FY26 earnings print this week is the proximate event for measuring continued margin compounding and any update on the project backlog conversion timeline. The deeper thesis question is whether the hydrogen / clean-energy project pipeline (where Linde is a consortium partner on multiple Gulf Coast blue-hydrogen + ammonia projects) extends the compounding beyond the current backlog horizon.